Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)

March 2000

Glaxo is now starting to promote Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS).

This will be big.

Approx 30 million Americans have irritable bowel syndrome...leading to chronic abdominal pain, cramps, diarrhea and/or constipation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

whether hormone replacement therapy increases the risk of breast cancer
Gastroenterology Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)
Pediatrics Augmentin is more effective than Zithromax for otitis media
Pediatrics The first oral solution that contains ONLY trimethoprim
Immunizations new 2-dose regimen for giving Recombivax HB (hepatitis B vaccine) to ADOLESCENTS
Immunizations more widespread use of varicella vaccine (Varivax)
Cardiology whether vitamin E reduces the risk of heart disease
Women's Health Ortho-Prefest, a new combo HRT regimen for postmenopausal women
Women's Health metformin for Polycystic Ovary Syndrome (PCOS)
Ophthalmology three new eye drops for itching due to allergic conjunctivitis
Infectious Diseases Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia
Infectious Diseases Sporanox (itraconazole) now comes in IV form
which calcium supplement to recommend for a particular patient
Antiepileptics two new anti-epileptics
drug interactions with St. John's wort